Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients. Dirven L, Musoro JZ, Coens C, Reijneveld JC, et al. Neuro Oncol 2021 Feb 18. pii: 6142946. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Dirven L, Musoro JZ, Coens C, Reijneveld JC, et al. Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients. Neuro Oncol 2021 Feb 18. pii: 6142946. doi: 10.1093.
PMID: 33598685